Schedule 13G ownership disclosure
AMBRX BIOPHARMA INC
Security class unavailable · CUSIP: 02290A102
Event date: 2023-09-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-103570
- Form type
- SC 13G
- Filer
- Ambrx Biopharma Cayman, Inc.
- CIK
- CIK 1836056
- Filed
- Sep 25, 2023
- Reporting period
- Sep 14, 2023
- Description
- Schedule 13G beneficial ownership